نظام معلومات الأدوية

رقم التسجيل

2206222245

سنة التسجيل

2013

الاسم التجاري

JOINTACE COLLAGEN TABLET

الاسم العلمي

GLUCOSAMINE SULFATE,COLLAGEN TYPE II,CHONDROITIN,COPPER,GINGER EXTRACT,MANGANESE,TOCOPHEROL,ZINC OXIDE,ASCORBIC ACID,CHOLECALCIFEROL,CYANOCOBALAMIN,FOLIC ACID,SELENIUM SULFIDE

التركيز

500,150,50,0.50,40,2,20,5,30,5,10,200,60

وحدة التركيز

طريقة الإستعمال

Oral use

الشكل الصيدلاني

Tablet

الحجم

وحدة الحجم

حجم العبوة

60

انواع العبوات

Blister

طريقة الصرف

OTC

حالة المراقبة

Uncontrolled

نوع الدواء

Generic

مدة الصلاحية بالأشهر

36

شروط التخزين

store below 25°c

سعر الجمهور بالريال ( السعر )

54.6

المصنع

THOMPSON & CAPPER

الوكيل

MANAYER NAJD TRADING MEDICAL NEEDS CO.

الشركة المسوقة

VITABIOTICS LTD

كود الكيمياء العلاجية التشريحية 1

M01AX05

كود الكيمياء العلاجية التشريحية 2

لم يتم إدخال بيانات نشرة معلومات المريض لهذا الدواء حتى الآن

Read this leaflet carefully before you start using this product as it contains important information for you

1. NAME OF THE MEDICINAL PRODUCT

Jointace Collagen

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Glucosamine Sulphate 500 mg Collagen Type II 150 mg Chondroitin Sulphate 50 mg Vitamin E 20 mg Vitamin D 5 μg Vitamin B12 10 μg Vitamin C 30 mg Folic Acid 200 μg Selenium 60 μg Zinc 5 mg Copper 0.5 mg Manganese 2 mg Ginger Extract 40 mg

3. PHARMACEUTICAL FORM

Tablet

4. CLINICAL PARTICULARS

4.1 Therapeutic Indications

This product is a multivitamin and mineral dietary supplement, for the preventioo ami conrectiollll ofi vitamin
and mineral deficiency states.

4.2 Posology And Method Administration

2 Tablet (s) per day, with your main meal. Swallow with a
fu ll glass of water or a cold drink. Not to be chewed. Do not exceed the recommended! Intake.

4.3 Contraindications

None known

4.4. Special warnings and precautions for use

None. To be taken as directed. See point 4.2 above

4.5. Interactions with other medicinal products

None.

4.6. Fertility, pregnancy and lactation

None.

4.7. Effects on ability to drive and use machines

None.

4.8. Undesirable effects

None

4.9. Overdoes

Discontinue use. Seek immediate medical advice

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic Properties

Not applicable for vitamin and mineral dietary supplemnts

5.2. Pharmacokinetic Properties

Not applicable for vitamin and mineral dietary supplements.

5.3 Preclinical Safety Data

The ingredeints are well established, and well documented in published scientiiic litemtme, worlc;lf.wi<Ue.

6. PHARMACEUTICAL PARTICULARS

6.1 Excipients List

Dibasic Calcium Phosphate
Microcrystalline Cellulose
Polyvinylpyrrolidone
Purified Talc, Magnesium Silicate Prep.
Syloid - (Colloidal Silica, Silicon Dioxide)
Potato Starch
Polyvinylpolypyrrol idone
Polyethylene Glycol 6000
Magnesium Stearate
Hyd roxyp ropyl m ethylcell ulose

Hydroxypropylmethylcellulose
Polyethylene Glycol 6000
Titanium Dioxide
Iron Oxide Red

6.2. Incompatibilities

None known.

6.3. Shelf Life

3 years

6.4. Special precautions for storage

Store below 25"C,protect from light. out of siQht and reach of children.

6.5. Nature and contents of container

60 Tablet (s):
15 Tablet (s) per blister strip
II blister strips per box.
in a dry place
Description of the product:
Redish Brown. capsule shaped, film coated table!

6.6. Special precautions for disposal and other handling

Not applicable.

7. MARKETING AUTHORISATION HOLDER

Vitabiotics Ltd. 1 Apsley Way London NW27HF

8. DATE OF REVISION OF THE TEXT

na

}

Search Results

صورة المنتج على الرف

الصورة الاساسية